[HTML][HTML] Metformin directly binds to MMP-9 to improve plaque stability

X Chen, S Wang, W Xu, M Zhao, Y Zhang… - Journal of Cardiovascular …, 2023 - mdpi.com
Vulnerable atherosclerotic plaque rupture is the principal mechanism that accounts for
myocardial infarction and stroke. High matrix metalloproteinase-9 (MMP-9) expression and …

The role of matrix metalloproteinase‐9 in atherosclerotic plaque instability

T Li, X Li, Y Feng, G Dong, Y Wang… - Mediators of …, 2020 - Wiley Online Library
Matrix metalloproteinase‐9 (MMP‐9) belongs to the MMP family and has been widely
investigated. Excessive MMP‐9 expression can enhance extracellular matrix degradation …

Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a …

C Cevik, M Otahbachi, K Nugent… - Journal of …, 2008 - journals.lww.com
Atherosclerotic plaques are composed of a lipid rich core, which is covered by a collagen
rich fibrous cap. Rupture of the atherosclerotic plaque with superimposed thrombosis is the …

Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

A Purroy, C Roncal, J Orbe, O Meilhac, M Belzunce… - Atherosclerosis, 2018 - Elsevier
Background and aims Matrix metalloproteinases (MMPs) have been implicated in
atherosclerosis and vascular calcification. Among them, we reported that MMP10 is present …

The expression of matrix metalloproteinases-9, transforming growth factor-β1 and transforming growth factor-β receptor I in human atherosclerotic plaque and their …

X Jiang, H Zeng, Y Guo, Z Zhou, B Tang… - Chinese medical …, 2004 - mednexus.org
Background Transforming growth factor beta (TGF-β) and matrix metalloproteinases-9 (MMP-
9) have been implicated in the pathogenesis of human atherosclerosis but their relationship …

Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis

R De Nooijer, CJN Verkleij… - … , and vascular biology, 2006 - Am Heart Assoc
Background—Matrix metalloproteinase-9 (MMP-9) is involved in atherosclerosis and
elevated MMP-9 activity has been found in unstable plaques, suggesting a crucial role in …

Multidimensional contribution of matrix metalloproteinases to atherosclerotic plaque vulnerability: multiple mechanisms of inhibition to promote stability

JM Ruddy, JS Ikonomidis, JA Jones - Journal of vascular research, 2016 - karger.com
The prevalence of atherosclerotic disease continues to increase, and despite significant
reductions in major cardiovascular events with current medical interventions, an additional …

Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability

C Furman, C Copin, M Kandoussi, R Davidson… - Atherosclerosis, 2004 - Elsevier
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have
been shown to reduce cardiovascular morbidity and mortality by their actions on atherogenic …

Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis

T Quillard, Y Tesmenitsky, K Croce… - … , and vascular biology, 2011 - Am Heart Assoc
Objective—Evidence has linked collagen loss with the onset of acute coronary events. This
study tested the hypothesis that selective matrix metalloproteinase-13 (MMP-13) …

[HTML][HTML] Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients

C Cevik, K Nugent, G Meyerrose… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
Matrix metalloproteinases degrade the collagen content of atherosclerotic plaque and
reduce plaque stability. In tissue sections of atherosclerotic plaque, the expression of matrix …